Scholarlink

<p>Antimicrobial resistance poses a critical global threat, with carbapenem-resistant pathogens representing a significant challenge to healthcare systems. This study aimed to characterize carbapenem-resistant pathogens isolated from wound infections in patients from a major hospital in Trinidad using a combination of traditional microbiological and molecular techniques. A total of 25 Gram-negative bacterial isolates were analyzed phenotypically for antimicrobial resistance and genetically profiled for resistance mechanisms using polymerase chain reaction and whole genome sequencing. Analysis of the data revealed most of the isolates were <i>Acinetobacter baumannii</i> (<i>A. baumannii)</i> (56%; n = 14) and <i>Klebsiella pneumoniae</i> (<i>K. pneumoniae)</i> (28%; n = 7), but a small number of <i>Enterobacter</i> (12%; n = 3), and <i>Pseudomonas</i> (4%; n = 1) were also identified. While the isolates were determined to be carbapenem resistant, 32% (n = 8) also exhibited extended spectrum beta-lactamases characteristics. Key resistance determinants identified from whole genome sequencing included <i>bla</i><sub><i>OXA-23</i></sub> (n = 2)<i>, bla</i><sub><i>OXA-90</i></sub> (n = 2), and <i>bla</i><sub><i>OXA-72</i></sub> (n = 1) in <i>A. baumannii</i> and <i>bla</i><sub><i>NDM-5</i></sub> (n = 1) in <i>K. pneumoniae</i>. The co-occurrence of carbapenemase and extended spectrum beta-lactamase genes, such as <i>bla</i><sub><i>CTXM-124</i></sub> in <i>A. baumannii</i> and bla<sub><i>TEM-1B</i></sub> and <i>bla</i><sub><i>CMY-4</i></sub> in <i>K. pneumoniae</i>, emphasized the complexity of resistance mechanisms that limits therapeutic options. Notably, this is the first study to report on the occurrence of <i>bla</i><sub><i>SPM</i></sub> and <i>bla</i><sub><i>SME</i></sub> in <i>A. baumannii</i> in Trinidad. By contributing critical insights into the molecular epidemiology of antimicrobial resistance in the setting of the Caribbean, this study offers a foundation for region-specific interventions to mitigate the clinical and economic impact of resistant infections. It will also help improve antimicrobial stewardship, and control efforts, and therefore supports the need for investment in diagnostic stewardship.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Analysis of Clinical Gram-Negative Carbapenem Resistant Acinetobacter baumannii and Klebsiella pneumoniae Isolates from Wounds of Patients at a Hospital Reveals Complex Resistome and the First Report of blaSPM and blaSME Genes in Trinidad, West Indies

  • 期刊论文

  • 发表日期：

    2025年11月5日

查看全文
  • Sherine Chandanee Nandlal,
  • Aarti Pustam,
  • Rajeev P. Nagassar,
  • Jayaraj Jayaraman,
  • Adesh Ramsubhag

摘要

Antimicrobial resistance poses a critical global threat, with carbapenem-resistant pathogens representing a significant challenge to healthcare systems. This study aimed to characterize carbapenem-resistant pathogens isolated from wound infections in patients from a major hospital in Trinidad using a combination of traditional microbiological and molecular techniques. A total of 25 Gram-negative bacterial isolates were analyzed phenotypically for antimicrobial resistance and genetically profiled for resistance mechanisms using polymerase chain reaction and whole genome sequencing. Analysis of the data revealed most of the isolates were Acinetobacter baumannii (A. baumannii) (56%; n = 14) and Klebsiella pneumoniae (K. pneumoniae) (28%; n = 7), but a small number of Enterobacter (12%; n = 3), and Pseudomonas (4%; n = 1) were also identified. While the isolates were determined to be carbapenem resistant, 32% (n = 8) also exhibited extended spectrum beta-lactamases characteristics. Key resistance determinants identified from whole genome sequencing included blaOXA-23 (n = 2), blaOXA-90 (n = 2), and blaOXA-72 (n = 1) in A. baumannii and blaNDM-5 (n = 1) in K. pneumoniae. The co-occurrence of carbapenemase and extended spectrum beta-lactamase genes, such as blaCTXM-124 in A. baumannii and blaTEM-1B and blaCMY-4 in K. pneumoniae, emphasized the complexity of resistance mechanisms that limits therapeutic options. Notably, this is the first study to report on the occurrence of blaSPM and blaSME in A. baumannii in Trinidad. By contributing critical insights into the molecular epidemiology of antimicrobial resistance in the setting of the Caribbean, this study offers a foundation for region-specific interventions to mitigate the clinical and economic impact of resistant infections. It will also help improve antimicrobial stewardship, and control efforts, and therefore supports the need for investment in diagnostic stewardship.